Physician profile
Jennifer S Bracamontes
NPI 1942663190
$15,161.65
in general payments reported to CMS, 2019-2025
8 companies · $13K in 2025
The $13K reported for 2025 was more than what 91% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $84.42 · 2023: $287 · 2024: $1,352 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,492 · Consulting Fee: $4,505 · Food and Beverage: $1,360 · Travel and Lodging: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,491.50 |
| Consulting Fee | $4,505.00 |
| Food and Beverage | $1,360.25 |
| Travel and Lodging | $720.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $8,616.50 | 2024-2025 | |
| Genzyme Corporation | $3,105.05 | 2025 | |
| Alexion Pharmaceuticals, INC. | $1,595.00 | 2025 | Strensiq |
| Medtronic, INC. | $1,410.82 | 2023-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Beta Bionics, INC. | $125.00 | 2024 | Ilet Bionic Pancreas |
| Abbott Laboratories | $121.27 | 2023 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $103.59 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $84.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Bracamontes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.